Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
Clinical trial NCT02662114 · COMPLETED
Trial details
- NCT number
- NCT02662114
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-08
- Primary completion
- 2016-08-12
- Enrollment
- 2302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.